Optimal Asset Management Inc. increased its stake in HCA Healthcare Inc (NYSE:HCA) by 87.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 18,423 shares of the company’s stock after purchasing an additional 8,582 shares during the quarter. Optimal Asset Management Inc.’s holdings in HCA Healthcare were worth $1,655,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in the business. Cutler Group LP grew its holdings in shares of HCA Healthcare by 102.1% during the first quarter. Cutler Group LP now owns 300 shares of the company’s stock worth $26,000 after buying an additional 14,400 shares in the last quarter. City Holding Co. lifted its holdings in shares of HCA Healthcare by 903.2% during the first quarter. City Holding Co. now owns 311 shares of the company’s stock valued at $28,000 after purchasing an additional 280 shares during the last quarter. Bessemer Group Inc. lifted its holdings in shares of HCA Healthcare by 57.8% during the first quarter. Bessemer Group Inc. now owns 363 shares of the company’s stock valued at $33,000 after purchasing an additional 133 shares during the last quarter. Solstein Capital LLC bought a new stake in shares of HCA Healthcare during the first quarter valued at approximately $36,000. Finally, Penserra Capital Management LLC increased its position in shares of HCA Healthcare by 50.8% during the fourth quarter. Penserra Capital Management LLC now owns 294 shares of the company’s stock valued at $41,000 after acquiring an additional 99 shares in the last quarter. 68.71% of the stock is currently owned by institutional investors.

Shares of HCA traded down $0.50 during trading hours on Friday, reaching $92.85. 696,199 shares of the stock traded hands, compared to its average volume of 2,707,352. HCA Healthcare Inc has a 52-week low of $58.38 and a 52-week high of $151.97. The company’s 50-day moving average price is $104.93 and its two-hundred day moving average price is $121.74. The company has a market cap of $31.52 billion, a P/E ratio of 10.60, a price-to-earnings-growth ratio of 2.08 and a beta of 1.28.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Tuesday, April 21st. The company reported $2.33 EPS for the quarter, missing the consensus estimate of $2.64 by ($0.31). The company had revenue of $12.86 billion during the quarter, compared to analysts’ expectations of $13.12 billion. HCA Healthcare had a negative return on equity of 304.76% and a net margin of 5.90%. The firm’s revenue for the quarter was up 2.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.97 EPS. Equities research analysts expect that HCA Healthcare Inc will post 4.89 earnings per share for the current fiscal year.

Several brokerages recently weighed in on HCA. Oppenheimer reduced their price target on shares of HCA Healthcare from $160.00 to $135.00 and set an “outperform” rating for the company in a research report on Wednesday, April 22nd. Mizuho cut their target price on shares of HCA Healthcare from $150.00 to $136.00 and set a “buy” rating for the company in a research report on Friday, May 29th. Credit Suisse Group reaffirmed a “buy” rating and issued a $173.00 target price on shares of HCA Healthcare in a research report on Thursday, March 19th. Raymond James cut their target price on shares of HCA Healthcare from $165.00 to $130.00 and set an “outperform” rating for the company in a research report on Monday, April 20th. Finally, Citigroup cut their target price on shares of HCA Healthcare from $168.00 to $131.00 and set a “buy” rating for the company in a research report on Wednesday, May 20th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and fifteen have given a buy rating to the company’s stock. HCA Healthcare has an average rating of “Buy” and a consensus target price of $147.81.

In other news, insider Jon M. Foster sold 24,220 shares of the company’s stock in a transaction dated Wednesday, May 6th. The shares were sold at an average price of $100.19, for a total transaction of $2,426,601.80. Following the sale, the insider now directly owns 49,212 shares in the company, valued at approximately $4,930,550.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 1.80% of the stock is currently owned by corporate insiders.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Further Reading: Diluted Earnings Per Share

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.